Alerts will be sent to your verified email
Verify Email
ORCHPHARMA
|
Orchid Pharma
|
Gufic Biosciences
|
Zota Health Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.86 % | 25.05 % | -1.91 % |
|
5yr Avg Net Profit Margin
|
0.56 % | 10.9 % | -0.52 % |
|
Price to Book
|
2.89 | 6.06 | 16.38 |
|
P/E
|
43.03 | 58.83 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
52.03 Days | 26.94 Days | 38.95 Days |
|
5yr Average Interest Coverage Ratio
|
3.01 | 13.1 | 18.17 |
|
5yr Avg ROCE
|
3.08 % | 27.25 % | 1.25 % |
|
5yr Avg Operating Profit Margin
|
11.84 % | 18.45 % | 5.05 % |
|
5 yr average Debt to Equity
|
0.37 | 0.51 | 0.03 |
|
5yr CAGR Net Profit
|
n/a | 14.26 % | n/a |
|
5yr Average Return on Assets
|
1.2 % | 11.52 % | -0.16 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.84 % | 72.52 % | 57.42 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.26 % |
|
Change in Promoter Holding (3 Yrs)
|
-20.12 % | -2.48 % | -10.7 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
16.13 % | 2.35 % | 0.0 |
|
Orchid Pharma
|
Gufic Biosciences
|
Zota Health Care
|
|---|